FMO5 and cardiac hypertrophy: In pressure overload-mediated cardiac hypertrophy, NADPH oxidase existing in myocardial cells is the main source of ROS production and may result in various pathophysiological changes such as the activation of redox enzyme and progression to ventricular remodeling [11].